With the goal of our futurre R& BD, competitive differentiation for new functional cosmetics based on new natural materials is summarized as follows.(Table 1)
Research
Competitive Differentiation
Table 1.
Differentiation Competitiveness |
New Raw Materials
-Registration for new use of cosmetic ingredient
-Conversion of single chemical compounds to natural extracts -Determination of active ingredient contentin natural extracts -Pilot manufacturing method with high efficiency -Competitive reasonable cost for preparation of natural extracts |
New Formualations
-Active ingredients from functional natural extracts
-Maximum rate of substitution to natural ingredients among all ingredients in functional cosmetics products All com ponents within EWG Grade 3 -Positioning to ward advanced multi-functional products based on high class |
New Raw Materials
-Using new biodegradable soft copolymers
Preparations of micro-trans dermal delivery system -Increase of skin absorbency of active ingredients -Maintainemce of stability in skin |
Natural PAK 1 Blockers for Anti-Melanogenic and Anti-Aging
Generally recoginized natural PAKI blockers and future Gragem’s research targets are listed in following Table 2. As Future Gragem’s research targets, the fact story 1S, 2H and 3A are partly described as No. 8, 9, and 10 in the Table 2.
Table 2. Lists of Natural PAK1 Blockes
| No | Material | Chemical Formula | Molecular Weight | Derived material | Function | Listing |
|---|---|---|---|---|---|---|
| 1 | Melatonin | C13H16N2O2 | 232.3 | Human hormone | Antioxidant | KCIA, INCI |
| 2 | Apigenin | C15H10O5 | 270.2 | Fruit vegetables | Antioxidant, Hair Conditioner | KCIA, INCI |
| 3 | Caffeic Acid | (HO)2C6H3CH=CHCO2H | 180.2 | Medicinal plants | Antioxidant, Fragrance | KCIA, INCI |
| 4 | Resveratrol | C14H12O3 | 228.2 | Berry | Antioxidant, Skin protectant | KCIA, INCI |
| 5 | Ester Caffeic Acid | C17H16O4 | 284.3 | Honeycomb Origin | Antioxidant | Not listed |
| 6 | Shikonin | C16H16O5 | 288.3 | Lithospermum Erythrorhizon Root | Antibacterial, Anti-inflammatory | Not listed |
| 7 | Glaucarubinone | C25H34O10 | 494.5 | Ailanthus altissima | Antitumor | Not listed |
| 8 | The Fact Story 1S | C6H11NOS2Gragem | - | Gragem | Antioxidant | KCIA, INCI |
| 9 | The Fact Story 2H | C13H10Gragem | - | Gragem | Antibaterial | KCIA |
| 10 | The Fact Story 3A | C19H24Gragem | - | Gragem | Antioxidant | KCIA |
In Vitro Experimental Evidence for the Effects of The Fact” Story 1S
The research results for anti-melanogenesis and anti-aging through experimental protocols are obtained from the assays for melanin Content and NO Production. From these results, “ The Fact” Story 1S represents preferably excellent whitening and anti-aging effects compared to Arbutin and ASA as experimental controls in following Figures 2 & 3, respectively.
Figure 2. Whitening Effect of “ The Fact” Story 1S as a PAK1 Blocker
Melanin Contents (%)
Figure 3. Anti-aging Effect of “ The Fact” Story 1S as a PAK1 Blocker
NO Production (%)
Appealability Evaluation for The Fact Story 1S
Appealability evaluations based on comparability between competitively recognized multifunctional skin care creams for men (187)and The Fact Story 1S (135) for newly formulated men’s multifunctional cosmetics are descibed in Figure 4 & 5. Especially, the 187 product would be positioned as the best commercial product considering quality and price in current multifuctional skin care creams for men. Preferably, no significant difference in the statistics at least for the comparable evaluation of the appealability.
Figure 4. Appealability Evaluation of Description for Two Formulations
Figure 5. Appealability Evaluation of Taste for Two Test Formulations
In Vivo Evaluation of Human Skin Suitability
In vivo evaluation of human skin suitability for newly developed men’s multifunctional cosmetics would be focused on not only anti-melanogenesis and anti-aging but also anti-wrinkle and anti-UV action. It was obtained through a certified contract research organization for the report to Korea Ministry of Food and Drug Safety (KMFDS) in the end of December, 2018.
Recently Achieved 2 Publications and 1 Test Report table3.
| Title | Joural Name |
|---|---|
| In Vitro Assessment of Irritation Potential of an Anti- Melanogenic Agent, PF3758309, in a Reconstructed Human Epidermis Model | Asian J. Beauty Cosmetol. 2018; 16(3): 417-425 |
| Development of novel mixed-composition to increase antioxidant and whitening effects of 1S | Journal of the Society of Cosmetic Scientists of Korea, Volume 44 (3), December 2018 |
| Research Report for Inhibitions of NO Production, Melanin Synthesis and Antioxidation of PF-3758309 | Test Report by Ellead Skin & Bio Research |
Recently Filed 2 Patents table4.
| Title of Invention | Application No. (Date) |
|---|---|
| Whitening cosmetic compositions and whitening cosmetics using the same | 10-2018-0121310 (2018.10.10) |
| Complex Functionality Based Cosmetic Compositions and Functional Cosmetic Products Using The Same | 10-2018-0129588 (2018.10.29) |
Recent Publications and Patent Positions for Cosmetic PAK1 Blocker
One publication for “The Fact” Story 1S” was submitted in the “Journal of the Society of Cosmetic Scientists of Korea” on October, 2018 and expected to be published on December, 2018, titled as “ The Natural Fact 1S Based New multifunctional Cosmetic Formulation. Expected to be filed as a Korean Patent on September, 2018.
Publications and Patent Positions for In Vitro 3D Microfluidic Cultivation Methods of Cancer Stem Cells (CSCs) in Our Prior Research
Our prior research was focused on “In Vitro Microvessel Growth and Remodeling within a Three-dimensional Microfluidic Environment”. Using simple 3D microfluidics. (Ref. Cellular and Molecular Bioengineering, 2014 Mar 1;7(1): 15-25). The patent registration numbers and dates of not only Korea and global patents for the publications are listed in the following Table 5.
Table 5. Patent Registration Nubmers and Dates ( Patent List for CEO Inventor )
| No | Countries | Registration No. | Registration Date |
|---|---|---|---|
| 1 | Canada | CA 2813211 | October 24, 2017 |
| 2 | Japan | JP 6170431 | July 7, 2017 |
| 3 | Korea | KR 10-1720378 | March 21, 2017 |
| 4 | China | CN 103477222 | August 10, 2016 |
| 5 | USA | US 9261496 | Feb 16, 2016 |
